The MFDS ensures the safety of new drugs in South Korea through a comprehensive evaluation process that includes clinical trials, risk assessments, and safety monitoring. It reviews data on drug efficacy and potential side effects before approval, mandates post-marketing surveillance, and requires adverse event reporting to address safety concerns promptly.
